Lemaitre Vascular (LMAT) Misses Q1 EPS by 3c, Beats on Revenue; Offers FY25 Guidance

Lemaitre Vascular (NASDAQ: LMAT) reported Q1 EPS of $0.48, $0.03 worse than the analyst estimate of $0.51. Revenue for the quarter came in at $59.9 million versus the consensus estimate of $58.13 million.

GUIDANCE:

Lemaitre Vascular sees FY2025 EPS of $2.07-$2.24, versus the consensus of $2.23. Lemaitre Vascular sees FY2025 revenue of $242-249 million, versus the consensus of $239 million.

For earnings history and earnings-related data on Lemaitre Vascular (LMAT) click here.

You May Also Be Interested In

• Cineverse Corp (CNVS) Misses Q1 EPS by 20c; Offers Guidance
• Sensus Healthcare, Inc. (SRTS) Misses Q2 EPS by 41c
• First Tracks Biotherapeutics, Inc. (TRAX) Reports Q2 Loss of $0.95